Parnax Lab

{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "118.50",
    "chg": -3.65,
    "chgp": "-2.99%",
    "dir": -1,
    "prev_price": "122.15",
    "mcapval": "140.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE383L01019",
    "curr_date": "Feb 11",
    "curr_time": "",
    "bse_nse_vol": "4.02 k",
    "exc_status": "Active",
    "traded_date": "Feb 11, 2026",
    "traded_date_str": "2026 02 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Underperformance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-technical-weakness-and-underperformance-3827984",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParnaxLabLtd_mojoScore_3827984.png",
        "date": "2026-02-09 08:04:04",
        "description": "Parnax Lab Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, driven primarily by a deterioration in technical indicators despite some positive financial metrics. The company’s overall Mojo Score has declined to 34.0, reflecting a cautious stance amid mixed signals across quality, valuation, financial trends, and technicals."
      },
      {
        "title": "When is the next results date for Parnax Lab Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-parnax-lab-ltd-3825097",
        "imagepath": "",
        "date": "2026-02-06 23:17:24",
        "description": "The next results date for Parnax Lab Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-by-marketsmojo-amid-technical-and-financial-improvements-3815603",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ParnaxLabLtd_mojoScore_3815603.png",
        "date": "2026-02-02 08:05:59",
        "description": "Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 1 February 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering challenges in long-term fundamentals and recent market underperformance."
      },
      {
        "title": "Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3804428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ParnaxLabLtd_mojoScore_3804428.png",
        "date": "2026-01-26 08:05:10",
        "description": "Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 January 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quarterly performance. The company’s current Mojo Score stands at 34.0, with a Sell grade, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Parnax Lab Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-valuation-3801010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ParnaxLabLtd_mojoScore_3801010.png",
        "date": "2026-01-23 08:01:21",
        "description": "Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold as of 22 January 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite recent underperformance relative to the broader market, the company’s financial trends and quality parameters have shown signs of stabilisation, prompting a reassessment of its investment potential."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-3783241",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ParnaxLabLtd_mojoScore_3783241.png",
        "date": "2026-01-06 10:10:10",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-3771327",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ParnaxLabLtd_mojoScore_3771327.png",
        "date": "2025-12-26 15:12:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Parnax Lab Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-upgraded-to-hold-by-marketsmojo-amid-technical-and-financial-improvements-3758321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ParnaxLab_mojoScore_3758321.png",
        "date": "2025-12-15 08:04:40",
        "description": "Parnax Lab, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by evolving technical indicators and recent financial disclosures. While the stock’s recent price movements and quarterly results present a complex picture, the changes in evaluation metrics reflect a nuanced view of its current standing within the industry."
      },
      {
        "title": "Parnax Lab’s Market Assessment Reflects Mixed Signals Amidst Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-downgraded-to-sell-amid-technical-weakness-and-market-underperformance-3752732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ParnaxLab_mojoScore_3752732.png",
        "date": "2025-12-09 08:08:53",
        "description": "Parnax Lab, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market evaluation driven primarily by technical indicators, despite showing some positive financial metrics in recent quarters. The stock’s performance over the past year contrasts sharply with broader market trends, prompting a reassessment of its investment profile across quality, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 257,
    "sid": "286243",
    "stock_news_url": "https://www.marketsmojo.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine Months Ended 31St December 2025.",
      "datetime": "05-Feb-2026",
      "details": "Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q3) and Nine Months ended 31st December 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "22-Jan-2026",
      "details": "Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018 for quarter ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Dec-2025",
      "details": "Intimation of Closure of Trading Window for the quarter and nine months ended 31st December 2025 and shall open 48 hours after the Unaudited Financials Results become generally available to the public.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Underperformance

2026-02-09 08:04:04

Parnax Lab Ltd has seen its investment rating downgraded from Hold to Sell as of 6 February 2026, driven primarily by a deterioration in technical indicators despite some positive financial metrics. The company’s overall Mojo Score has declined to 34.0, reflecting a cautious stance amid mixed signals across quality, valuation, financial trends, and technicals.

Read full news article

When is the next results date for Parnax Lab Ltd?

2026-02-06 23:17:24

The next results date for Parnax Lab Ltd is scheduled for 13 February 2026....

Read full news article

Parnax Lab Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements

2026-02-02 08:05:59

Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 1 February 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial trends, despite some lingering challenges in long-term fundamentals and recent market underperformance.

Read full news article

Parnax Lab Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-01-26 08:05:10

Parnax Lab Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 23 January 2026. This revision reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quarterly performance. The company’s current Mojo Score stands at 34.0, with a Sell grade, signalling caution for investors amid a challenging market backdrop.

Read full news article

Parnax Lab Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Valuation

2026-01-23 08:01:21

Parnax Lab Ltd has seen its investment rating upgraded from Sell to Hold as of 22 January 2026, reflecting a notable improvement in its technical outlook and valuation metrics. Despite recent underperformance relative to the broader market, the company’s financial trends and quality parameters have shown signs of stabilisation, prompting a reassessment of its investment potential.

Read full news article

Parnax Lab Ltd is Rated Hold

2026-01-06 10:10:10

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Parnax Lab Ltd is Rated Hold

2025-12-26 15:12:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Parnax Lab Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-15 08:04:40

Parnax Lab, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in market assessment driven by evolving technical indicators and recent financial disclosures. While the stock’s recent price movements and quarterly results present a complex picture, the changes in evaluation metrics reflect a nuanced view of its current standing within the industry.

Read full news article

Parnax Lab’s Market Assessment Reflects Mixed Signals Amidst Technical Weakness

2025-12-09 08:08:53

Parnax Lab, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market evaluation driven primarily by technical indicators, despite showing some positive financial metrics in recent quarters. The stock’s performance over the past year contrasts sharply with broader market trends, prompting a reassessment of its investment profile across quality, valuation, financial trends, and technical outlook.

Read full news article

View All News